Worsening Vision

Slideshow

Case History: 27-year-old male with worsening vision in the left eye for five months.

Case History: A 27-year-old male presents to the  emergency department with complaints of worsening vision in the left eye for the past five months.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Subscribe Now!
Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Related Content
Can AI Enhance Ultrasound Detection of Cardiac Amyloidosis? What a Multicenter Study Reveals

Can AI Enhance Ultrasound Detection of Cardiac Amyloidosis? What a Multicenter Study Reveals

Jeff Hall
July 11th 2025
Article

EchoGo Amyloidosis, an echocardiography-based AI screening software, demonstrated a 93 percent AUROC for cardiac amyloidosis detection in a new multicenter study.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

New FDA-Approved Dosing Schedule for Donanemab May Reduce ARIA-E Rates

New FDA-Approved Dosing Schedule for Donanemab May Reduce ARIA-E Rates

Jeff Hall
July 9th 2025
Article

Findings from the TRAILBLAZER-ALZ 6 study revealed a 41 percent reduction of the ARIA-E side effect at 24 weeks with the new dosing schedule for the anti-amyloid treatment donanemab-azbt.

The Reading Room: Potential fMRI Alternative -- fPACT

The Reading Room: Potential fMRI Alternative -- fPACT

Whitney J. Palmer
June 23rd 2021
Podcast

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

FDA Clears Emerging 3D Ultrasound Technology

FDA Clears Emerging 3D Ultrasound Technology

Jeff Hall
July 2nd 2025
Article

The diagnostic tomographic 3D ultrasound imaging technology PIUR tUS inside will reportedly be available with select GE HealthCare Logiq systems.

FDA Clears SmartSpeed Precise MRI Software from Philips

FDA Clears SmartSpeed Precise MRI Software from Philips

Jeff Hall
July 2nd 2025
Article

The deep learning reconstruction software reportedly facilitates accelerated MRI scanning and significantly enhanced image sharpness.

© 2025 MJH Life Sciences

All rights reserved.